Per3 VNTR polymorphism and chronic heart failure

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014;158(1):80-3. doi: 10.5507/bp.2012.069. Epub 2012 Oct 30.

Abstract

Aims: The aim of this study was to investigate the relationship between gene Period3 (Per3) variable number tandem repeat (VNTR) polymorphism and chronic heart failure (CHF).

Methods: The study subjects (372 patients of Caucasian origin with CHF and 332 healthy controls) were genotyped for Per3 VNTR polymorphism using an allele-specific PCR.

Results: No significant differences in genotype or Per3 VNTR allele frequencies were found between CHF cases and controls (Pg=0.30, Pa=0.52). No significant differences were uncovered either between CHF cases according to etiology (DCMP vs. IHD; Pg=0.87, Pa=0.91). In the multivariate regression modeling, no predictive function of VNTR Per3 polymorphism on ejection fraction or NYHA class, hyperlipidaemia or type II diabetes risk was found.

Conclusion: Per3 VNTR polymorphism is not a major risk factor for chronic heart failure or a factor modulating the severity of the CHF in this population.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Chronic Disease
  • Female
  • Gene Frequency
  • Heart Failure / genetics*
  • Humans
  • Male
  • Middle Aged
  • Minisatellite Repeats*
  • Period Circadian Proteins / genetics*
  • Polymorphism, Genetic
  • Young Adult

Substances

  • PER3 protein, human
  • Period Circadian Proteins